# Medical Tourism Market > Medical Tourism Market Research Report Information by Treatment Type (Orthopaedic, Ophthalmology, Oncology, Cosmetic Surgery, Cardiovascular, Dentistry, Neurology, Fertility, Others), By Service Provider (Public, Private), By Region (North America, Europe, Asia-Pacific, Rest of the World) - Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 18.2% - **2024:** $ 49,279.57 Million - **2025:** $ 58,248.4 Million - **2035:** $ 292,866.1 Million - **Key Players:** Companies such Fortis Healthcare, Apollo Hospitals, Bumrungrad International Hospital, Medanta, Bangkok Hospitals, Raffles Medical Group, Asklepios Kliniken GmbH & Co. KGaA are some of the major participants in the global market. **Report ID:** MRFR/MED/1443-CR · **Pages:** 90 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** June 26, 2026 **URL:** https://www.marketresearchfuture.com/reports/medical-tourism-market-1975 --- ## Market Summary The global medical tourism market size was estimated at USD 58.248 Million in 2025 and is expected to reach USD 2,92,866.10 Million by 2035, growing at a CAGR of 18.2% from 2025 to 2035. Major growth drivers include low-cost treatments in developing countries, advanced procedures, modern hospitals, skilled doctors, improved connectivity, and personalized patient care.   Rising cost disparity in healthcare and increasing awareness of affordable high-quality treatment abroad are driving medical tourism growth. Patients prefer cross-border care for surgeries, fertility, and wellness services supported by improved travel access, digital health platforms, and international hospital accreditation systems.   WHO global health datasets indicate that over 1.3 billion international tourist movements annually support cross-border healthcare accessibility, while advanced AI-enabled health data systems like Stanford AIMI show increasing adoption of digital diagnostics in over 60+ countries, improving treatment confidence and patient mobility for medical travel decisions. ## Market Drivers ### Low Cost of Medical Treatment in Developing Countries The low cost of medical treatment in developing countries has emerged as one of the most powerful drivers of medical tourism market, encouraging patients from developed nations to seek care abroad where healthcare services are available at a fraction of the cost while maintaining comparable quality.    In countries such as India, Thailand, Malaysia, Mexico, Turkey, and the Philippines, advanced medical procedures including cardiac surgery, orthopedic interventions, cosmetic enhancements, fertility treatments, and dental care—can cost 50–80% less than in the United States, Canada, or Western Europe, even after accounting for travel, accommodation, and additional expenses. - World Bank health expenditure data highlights that average healthcare spending per capita in developing nations such as India and Thailand remains under USD 300–500, compared to over USD 10,000 in the United States. This significant cost gap of nearly 70–80% lower treatment expenses continues to attract millions of patients seeking affordable, high-quality surgical and specialized medical care abroad.   This cost advantage is largely driven by lower labor costs, favorable currency exchange rates, and reduced administrative and insurance overheads in developing economies, allowing hospitals to deliver affordable yet high-quality care supported by internationally trained doctors and modern infrastructure.   Patients facing exorbitant costs or lack of insurance coverage in their home countries often find medical tourism a practical and attractive alternative, especially for elective or non-emergency procedures that can be planned in advance.   In September 2025, Fortis Healthcare launched a 200-bed multispecialty hospital in Greater Noida, strategically located near the upcoming Jewar International Airport. This proximity is expected to significantly boost cross-border patient inflow, making advanced healthcare more accessible to international travelers. By combining modern infrastructure with improved connectivity, the facility is poised to strengthen India’s position as a leading medical tourism destination. ## Future Outlook The Medical Tourism Market size is projected to reach USD 292,866.10 Million by 2035, growing at a CAGR of 18.2%, driven by increasing demand for high-performance computing and enhanced security features. **New opportunities:** - Expansion of Telemedicine and Virtual Consultations - Cross-Border Collaborations and Hospital Partnerships. By 2035, the Medical Tourism Market is expected to be robust, reflecting substantial growth and diversification. ## Segment Insights ### By Treatment Type: cosmetic surgery (largest market) vs oncology (fastest growing) Based on treatment type, the market has been segmented into orthopaedic, ophthalmology, oncology, cosmetic surgery, epilepsy, cardiovascular, dentistry, neurology, fertility, and others. Dentistry further segmented into dental implants, orthodontics, dental cosmetics, and others. The Cosmetic Surgery segment held the largest share of the Medical Tourism Market at 28% in 2024, while Fertility is the fastest-growing segment during the forecast period, i.e., 2025–2035. Bangkok Hospitals reported a 25% increase in cosmetic procedure-related international patients, supported by advanced aesthetic surgery units and minimally invasive technologies. Expansion of luxury recovery packages and bundled treatment services strengthened Thailand’s position as a global cosmetic surgery hub, significantly improving patient inflow from Europe and North America. ### By Service Provider: Private (largest market) vs Public (fastest-growing) Based on service provider, the market has been segmented into public and private. The private segment held the largest share of the Medical Tourism Market at 72% in 2024 and is also the fastest-growing segment during the forecast period, i.e., 2025–2035. Public service providers are playing an increasingly critical role in shaping and scaling medical tourism, particularly in nations with government-supported infrastructure that facilitates international patient interaction.  Raffles Medical Group recorded over 1.2 million patient visits annually, with international patient contribution growing steadily due to premium private care services. Expansion of integrated healthcare networks across Asia enhanced cross-border patient management, improving treatment accessibility, diagnostics speed, and overall satisfaction for medical tourists seeking private healthcare solutions. ## Regional Market Share Analysis **North America: Expanding domestic healthcare costs** The North America medical tourism market has shifted rapidly in responses to continuously high domestic healthcare costs, insurance gaps, and challenges to timely access.  Mexico has emerged as a popular destination for Americans seeking lower-cost dental and cosmetic services, both to geographic proximity and government efforts to promote health travel. - CDC healthcare utilization data shows over 60% of U.S. adults delay or avoid treatment due to high costs, reinforcing outbound medical tourism demand. GE Healthcare reports a 35% increase in cross-border imaging and diagnostic equipment usage, supporting international patient referrals. These factors strengthen Mexico and nearby destinations as preferred cost-effective treatment hubs for North American patients. In contrast, the United States, despite being an appealing location for medical tourists, attracts inbound patients seeking highly specialized care in oncology, cardiology, and advanced surgeries, offered by world-class facilities. Anecdotal evidence suggests that a retired US couple flew to Thailand, Vietnam, Mexico, and the Caribbean for cancer treatment for a cost of USD 18,807, saving almost USD 100,000 compared to US prices and bypassing Medicare constraints. A US patient chose a USD 4,000 hysterectomy in Colombia over a USD 15,000 to USD 40,000 treatment in the US. **Europe: Production healthcare systems** Europe medical tourism market accounted for USD 7,733.00 million in 2024 and is projected to grow at a CAGR of 15.88% during the forecast period. Europe is further segmented into the Germany, France, UK, Russia, Italy, Spain, and Rest of the Europe. Medical tourism has grown in prominence throughout Europe as patients seek more timely and cost-effective treatments in the midst of burdened home healthcare systems and long waiting lists. - European Medicines Agency approvals indicate over 150+ advanced therapies authorized in the past decade, improving treatment availability across EU hospitals. Combined with healthcare system pressure, countries like Germany and Spain report waiting time reductions of up to 40% through cross-border patient programs, driving outbound and intra-Europe medical tourism for faster access to specialized procedures. In the UK, post-COVID, the outflow began to accelerate. By 2022, around 350,000 UK residents traveled abroad for procedures (hip, knee replacements, cataracts, cardiology), up from around 248,000 in 2019, pushed mostly by overburdened NHS waiting times. Clinics in Lithuania, Poland, Croatia, and France are increasingly catering to these patients, providing faster access at reduced costs. A Highland patient's hip replacement in Poland, for instance, cost about half as much as private care in the UK. **Asia Pacific: Rising healthcare expenses** The Asia-Pacific medical tourism market has been strongly influenced by rising healthcare expenses in Western countries, the development of technologically advanced medical infrastructure throughout Asia, and increased consumer awareness of cross-border treatment choices. Since 2019, Thailand, India, Malaysia, and South Korea have attracted millions of patients each year seeking high-quality, low-cost medical operations ranging from cardiac surgery and orthopedics to cosmetic enhancements and fertility treatments. Thailand's combination of refined wellness with therapeutic services has made it a top destination, particularly for cosmetic and gender-affirming procedures. - Malaysia, which had over 1.22 million medical tourists in 2019, has emerged as a destination for cardiology, fertility, cancer, and dental treatments, with specialized patient centers and regional offices.  Thailand, a long-standing leader in the region, continues to draw international patients for cosmetic, wellness, and regenerative therapies, supported by world-class facilities and tourism integration. **Rest of the World: Growing strategic infrastructure investments** The Rest of the World medical tourism market has seen significant transformation, owing to a combination of strategic infrastructure investments, government initiatives, and growing patient flows. In the Middle East, the United Arab Emirates, particularly Dubai and Abu Dhabi, have established themselves as a leading worldwide healthcare destination. - In 2023, Dubai alone attracted roughly 691,000 medical tourists, who spent approximately AED 1 billion (nearly USD 280 million) on medical treatments. Its popularity arises from a seamless blend of high-end medical facilities, short treatment wait times, opulent recuperation alternatives, and integrated tourist, with platforms such as DXH offering one-stop access to consultations, accommodation, visas, and tourism packages. ## Competitive Benchmarking Many global, regional, and local vendors characterize the Medical Tourism Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.   The major players in the market Include Fortis Healthcare, Apollo Hospitals, Bumrungrad International Hospital, Medanta, Bangkok Hospitals, Raffles Medical Group, Asklepios Kliniken GmbH & Co. KGaA strategic market developments and decisions to improve operational effectiveness. ## Recent News & Developments **August 2025**: Apollo Health City, Hyderabad received the “International Medical Tourism Award” for Excellence in Customer Service from the International Medical Travel Journal, UK, at JW Marriott Hotel in Dubai. Apollo was the only Indian hospital to win the award, applauded for its dedication to international patient care. The award highlights Apollo’s role in enriching 37 million lives across 120 countries, strengthening India’s position as a global healthcare destination. Dr. Prathap C. Reddy, Founder and Chairman, was acknowledged for pioneering medical tourism in India, with Apollo reaffirming its commitment to advancing medical tourism globally. **June 2025**: Fortis Healthcare has been honored with the Medical Value Travel Award 2025 at Advantage Healthcare India; an international summit focused on strengthening India’s position as a global leader in medical value travel. This recognition highlights Fortis Healthcare’s significant contributions to enhancing India's reputation as a premier destination for medical tourism. **March 2025**: Samitivej International Children’s Hospital has expanded its facilities, marking a significant step forward in pediatric healthcare as Thailand continues to attract a growing number of medical tourists from the Gulf region. This development supports the country’s rising status as a global healthcare hub, particularly for patients from Asia and the Middle East. In 2023, Thailand’s medical tourism sector was valued at 29 billion THB, according to Statista. ## Report Scope | Market Size 2024 | 49,279.57 (USD Million) | | --- | --- | | Market Size 2025 | 58,248.4 (USD Million) | | Market Size 2035 | 2,92,866.10 (USD Million) | | Compound Annual Growth Rate (CAGR) | 18.2% (2025 - 2035) | | Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | Base Year | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2023 | | Market Forecast Units | USD Million | | Key Companies Profiled | Fortis Healthcare, Apollo Hospitals, Bumrungrad International Hospital, Medanta, Bangkok Hospitals, Raffles Medical Group, Asklepios Kliniken GmbH & Co. KGaA. | | Segments Covered | By Treatment Type, By Service Provider | | Key Market Opportunities | Expansion of Telemedicine and Virtual Consultations. Cross-Border Collaborations and Hospital Partnerships. | | Key Market Dynamics | Rising awareness about medical tourism among patients. Low cost of medical treatment in developing countries. | | Region Covered | North America, Europe, Asia Pacific, Rest of the world | ## Frequently Asked Questions **Q: How much is the Medical Tourism Market?** A: USD 2,92,866.10 Million (2035) **Q: What is the growth rate of the Medical Tourism Market?** A: 18.2% **Q: Which region held the largest market share in the Medical Tourism Market?** A: Asia Pacific **Q: Who are the key players in the Medical Tourism Market?** A: Fortis Healthcare, Apollo Hospitals, Bumrungrad International Hospital, Medanta, Bangkok Hospitals, Raffles Medical Group, Asklepios Kliniken GmbH & Co. KGaA. **Q: Which Service Provider had the largest market share in the Medical Tourism Market?** A: Private --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/medical-tourism-market-1975*